LinkedInยทFriday, 21 August 2026ยท5d ago
๐๐ซ๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐ ๐๐ฉ๐ฌ ๐ฅ๐ข๐ฆ๐ข๐ญ๐ข๐ง๐ ๐ฒ๐จ๐ฎ๐ซ ๐๐ซ๐ฎ๐ โ๐ฌ ๐ซ๐๐๐๐ก ๐ข๐ง ๐ฉ๐ซ๐๐๐ข๐ฌ๐ข๐จ๐ง ๐จ๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ? Our Idyllaโขโฆ
Biocartis
48,302 followers
๐๐ซ๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐ ๐๐ฉ๐ฌ ๐ฅ๐ข๐ฆ๐ข๐ญ๐ข๐ง๐ ๐ฒ๐จ๐ฎ๐ซ ๐๐ซ๐ฎ๐ โ๐ฌ ๐ซ๐๐๐๐ก ๐ข๐ง ๐ฉ๐ซ๐๐๐ข๐ฌ๐ข๐จ๐ง ๐จ๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ?
Our Idyllaโข Platform can help close these gaps.
Idyllaโข is a fully automated molecular testing platform with 3 hours TAT, few invalid results, suitable for any lab and a global reach.
Partnering with Biocartis means we develop Idyllaโข tests that identify the right biomarkers in your drugโs target population โ and ensure those tests are accessible wherever your drug needs to reach, closing multiple diagnostic gaps along the way.
Letโs find your entry point โ pharma-partnering@biocartis.com
#Oncology #MolecularDiagnostics #PharmaPartnering #DrugDevelopment #Idylla #Biocartis
โฅ 25
View on LinkedIn Cross-referenced
Related on the wire
๐ ๐๐๐ฌ๐๐๐โข ๐ฃ๐จ๐๐๐๐๐๐ง๐๐ข๐ก ๐๐๐๐๐๐๐๐๐ง๐ฆ ๐๐ญ ๐ฎ๐ฌ๐ฎ๐ฒ: ๐ฅ๐ฎ๐ฝ๐ถ๐ฑ ๐ก๐ง๐ฅ๐ ๐ณ๐๐๐ถ๐ผ๐ป ๐ฑ๐ฒ๐๐ฒ๐ฐ๐๐ถ๐ผ๐ปโฆ
๐ก๐๐ผ๐ ๐บ๐๐ฐ๐ต ๐ฑ๐ถ๐ณ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ ๐ฐ๐ฎ๐ป ๐ณ๐ฎ๐๐, ๐ฎ๐ฐ๐ฐ๐๐ฟ๐ฎ๐๐ฒ ๐ฏ๐ถ๐ผ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐บ๐ฎ๐ธ๐ฒ ๐๐ผโฆ
๐ ๐๐๐ฌ๐๐๐โข ๐ฃ๐จ๐๐๐๐๐๐ง๐๐ข๐ก ๐๐๐๐๐๐๐๐๐ง๐ฆ ๐๐ญ ๐ฎ๐ฌ๐ฎ๐ฒ: ๐๐
๐ฝ๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐๐๐ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ฏ๐ฒ๐๐ผ๐ป๐ฑโฆ
Revolutionize your CRC diagnostics with Idyllaโข ๐ โฑ๏ธSpeed up your therapy decisions and alleviate patient anxiety*! Rapidly identifyโฆ
๐ ๐๐๐ฌ๐๐๐โข ๐ฃ๐จ๐๐๐๐๐๐ง๐๐ข๐ก ๐๐๐๐๐๐๐๐๐ง๐ฆ ๐๐ญ ๐ฎ๐ฌ๐ฎ๐ฒ The first half of 2026 brought continued growth in peer-reviewedโฆ
Molecular biomarker results in ONLY 3 HOURS! ๐ก THINK IDYLLAโข Today, Biocartis offers tests and assays enabling rapid biomarker results inโฆ